Adrienne E . Perfilio Edwards, MD
Director, Faculty Development in Department of OBGYN
Affiliate Assistant Professor
Contact
School of Medicine
Obstetrics and Gynecology
Family Medicine Obstetrics Fellowship
Adrienne E . Perfilio Edwards, MD
Director, Faculty Development in Department of OBGYN
Affiliate Assistant Professor
Department
Obstetrics & Gynecology
Position
Affiliate Assistant Professor
Articles
- National Organization for Rare Disorders
Adrienne Perfilio, Lauren Walters, Nikita Baral Ovarian remnant syndrome (ORS) is seen in patients who have previously had both ovaries or fallopian tubes removed (salpingo-oophorectomy). It is caused when ovarian tissue is unintentionally left behind in surgery. This leftover tissue may still act like an ovary and produce hormones but can also develop ovarian diseases like cysts or other benign or cancerous growths. This tissue may also enlarge, putting pressure on surrounding structures. Symptoms of ORS might include pelvic pain, a pelvic mass, painful intercourse, abnormal uterine bleeding, or bladder/bowel problems. The diagnosis is based on hormonal evaluation and pelvic imaging. Treatment usually consists of surgically removing the remnant tissue. 2024 - Int. J. Mol. Sci.
Burnett Tarasiewicz M, Strother A, Farias-Eisner R et al, Early Endometrial Cancer Treatment: A Shifting Paradigm, Int J Mol Sci. 2020 in press -0001 - Int. J. Mol. Sci.
DeAngelo C, Burnett Tarasiewicz M, Strother A, Farias-Eisner R et al, Endometriosis and Cancer: A Malignant Molecular Profile, Int J Mol Sci. 2020 in press -0001 - Journal of Cancer Research and Clinical Oncology
Burnett Tarasiewicz M, Strother A, Farias-Eisner R et al, Predictors of Oncofertility: A Molecular Profile, J Cancer Res Therap Oncol 2020 in press -0001 - Journal of Cancer Research and Clinical Oncology
Burnett Tarasiewicz M, Strother A, Farias-Eisner R et al, Pro-Inflammatory Predictors of Pre-Eclampia: A molecular Profie, J Cancer Res Therap Oncol 2020 in press -0001